Humana supports new Medicare program to reduce out-of-pocket insulin costs

Humana issued the following comment on the Part D Senior Savings Model announced today by the Centers for Medicare and Medicaid Services (CMS):

The Part D Senior Savings Model is not only an innovative public-private partnership but also an important step forward for the 3.3 million people with Medicare who use insulin – a critical, life-saving medication. Humana enthusiastically supports this market-based solution, and as a sponsor of stand-alone Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage, we look forward to doing our part to bring the program to life.

The model allows Part D plans to offer fixed, predictable copays for insulin, and it builds on ongoing efforts to improve the health and well-being of Medicare beneficiaries, who could see an average annual out-of-pocket savings of $446 for their insulin. The demonstration also promises to improve outcomes and promote medication adherence among those Medicare beneficiaries living with diabetes, a disease that all too often can lead to debilitating and costly complications.

In addition, the model clears the way for Medicare Advantage plans to offer broader access to treatment and care for members with diabetes, such as transportation to a doctor’s appointment or time with a nutritionist. This is an important element in addressing social determinants of health in order to help slow chronic disease progression.

You might also like